Compounds > azimexon
Page last updated: 2024-08-23

azimexon and Delayed Hypersensitivity

azimexon has been researched along with Delayed Hypersensitivity in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goutner, A; Huchet, R; Mathé, G; Thomas, Y1
Bruley-Rosset, M; Florentin, I; Kiger, N; Martinez, J; Mathé, G; Schulz, J1
Bonardelle, D; Goutner, A; Nasrat, F; Rameau, G1
Bicker, U; Cortez-Campeao, D; Luckenbach, GA; Modolell, ML; Munder, PG1
Chirigos, MA; Lauer, L; Papademetriou, V; Stylos, WA1
Kowalczyk-Bronisz, SH; Zabska, R1

Other Studies

6 other study(ies) available for azimexon and Delayed Hypersensitivity

ArticleYear
[Immune monitoring of the cancer patient: suppressor cells and NK cells].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1980, Volume: 174, Issue:4

    Topics: Adjuvants, Immunologic; Aziridines; Cytotoxicity, Immunologic; Drug Hypersensitivity; Hodgkin Disease; Humans; Hypersensitivity, Delayed; Interferons; Killer Cells, Natural; Lung Neoplasms; Lymphokines; T-Lymphocytes, Regulatory

1980
In vivo immunomodulating properties of two synthetic agents: azimexon and tuftsin.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1980, Volume: 75

    Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antibody-Dependent Cell Cytotoxicity; Aziridines; Azirines; Female; Hypersensitivity, Delayed; Immunoglobulin Fragments; Lymphocytes; Macrophages; Mice; Mitogens; Spleen; Tuftsin

1980
Immunorestoration of anergic cancer patients by azimexon.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1980, Volume: 75

    Topics: Adjuvants, Immunologic; Aziridines; Azirines; Humans; Hypersensitivity, Delayed; Immunotherapy; Lymphocytes; Neoplasms; Tetradecanoylphorbol Acetate

1980
Immunomodulation by the new synthetic compound BM 12.531, 2-[2-cyanaziridinyl-(1)]-[2-carbamoylaziridinyl-(1)]-propane (azimexone).
    Experimental pathology, 1981, Volume: 19, Issue:1

    Topics: Animals; Antibody Formation; Aziridines; Azirines; Bone Marrow; Concanavalin A; Hypersensitivity, Delayed; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phytohemagglutinins; Rats; Sarcoma, Experimental

1981
The immunomodulatory effect on BM 12.531 (azimexon) on normal or tumored mice: in vitro and in vivo studies.
    Journal of immunopharmacology, 1980, Volume: 2, Issue:1

    Topics: Animals; Ascitic Fluid; Aziridines; Azirines; Cells, Cultured; Hypersensitivity, Delayed; Immunity, Cellular; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Macrophages; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; X-Rays

1980
Studies on the derivatives of aziridine. II. Synthesis and immunopharmacological analysis of substituted amides and anilides of alpha-aziridinyl-beta-/p-chlorobenzoyl/-propionic acid.
    Archivum immunologiae et therapiae experimentalis, 1987, Volume: 35, Issue:5

    Topics: Animals; Aziridines; Azirines; Chemical Phenomena; Chemistry; Chlorobenzoates; Edema; Graft vs Host Reaction; Hemolytic Plaque Technique; Hypersensitivity, Delayed; Immunity; Lethal Dose 50; Mice; Mice, Inbred BALB C; Propionates; Rosette Formation; Sheep

1987